Allison Schneider, a spokesperson for Novo Nordisk, the manufacturer of Ozempic and Wegovy, said in a statement that the company is aware of several compounding pharmacies claiming to offer compounded semaglutide and is taking action against these entities," though she did not provide further details
reports research support grants from Akero, AstraZeneca, Boehringer Ingelheim, BMS, 89bio, Eli Lilly & Company, Intercept, IONIS, Janssen, Madrigal, Metacrine, Merck, NorthSea Therapeutics, Novartis, Novo Nordisk, Oramed, Pfizer, Poxel and Sanofi
These differences were significant compared with the baseline values ( P 0.05) [Table 4]
Currently, five states offer unrestricted Medicaid coverage for Wegovy, and four states offer restricted coverage with prior authorization
The analysis showed that among adults not using PAP therapy, Zepbound was about five times more effective than placebo in reducing breathing disruptions , leading to 25 fewer breathing disruptions per hour with Zepbound and five with placebo